Jakob Brix Christensen

Amministratore Delegato presso Unibio AS

Health Technology

Process Industries

Profilo

Jakob Brix Christensen is currently the Co-Chief Executive Officer at Unibio.
AS since 2021.
Prior to this, he worked as the Director-Investor Relations at Origio A from 2007 to 2012, Senior Manager-Business Finance at Novozymes A from 2012 to 2013, Partner-Business Finance at Albumedix A from 2013 to 2015, and Chief Financial Officer at Bioporto A from 2016 to 2018.

Posizioni attive di Jakob Brix Christensen

Società	Posizione	Inizio
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Amministratore Delegato	27/06/2021

Tutte le posizioni attive di Jakob Brix Christensen

Precedenti posizioni note di Jakob Brix Christensen

Società	Posizione	Fine
BIOPORTO A/S	Direttore Finanziario/CFO	01/06/2018
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Corporate Officer/Principal	01/12/2015
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Corporate Officer/Principal	01/04/2013
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Public Communications Contact	01/04/2012

Vedi nel dettaglio l'esperienza di Jakob Brix Christensen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jakob Brix Christensen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIOPORTO A/S	Health Technology

Aziende private	4
Origio A/S Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.	Health Technology
Albumedix A/S Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark.	Health Technology
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Process Industries
Unibio AS Unibio AS BiotechnologyHealth Technology Unibio AS is a Danish biotechnology company that operates in an undisclosed location. The private company was founded in 2001, and its CEOs are Jakob Brix Christensen, Sten Bay Jørgensen, and David Richard Henstrom.	Health Technology

Vedi le connessioni aziendali